Radiation Prior to Chimeric Antigen Receptor T-Cell Therapy Is an Optimizing Bridging Strategy in Relapse/Refractory Aggressive B-Cell Lymphoma

被引：0
|
作者：
Yu, Qiuxia [1 ]
Zhang, Xiaoying [2 ]
Wang, Na [1 ]
Huang, Liang [1 ]
Li, Chunrui [3 ]
Zhang, Yicheng [1 ]
Zhou, Jianfeng [4 ]
Wang, Gaoxiang [1 ]
Cao, Yang [4 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165174
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10311 / 10312
页数：2
相关论文
共 50 条
  • [1] Radiation prior to chimeric antigen receptor T-cell therapy is an optimizing bridging strategy in relapsed/refractory aggressive B-cell lymphoma
    Yu, Qiuxia
    Zhang, Xiaoying
    Wang, Na
    Li, Chunrui
    Zhang, Yicheng
    Zhou, Jianfeng
    Wang, Gaoxiang
    Cao, Yang
    RADIOTHERAPY AND ONCOLOGY, 2022, 177 : 53 - 60
  • [2] Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
    Wright, Christopher M.
    LaRiviere, Michael J.
    Baron, Jonathan A.
    Uche, Chibueze
    Xiao, Ying
    Arscott, W. Tristram
    Anstadt, Emily J.
    Barsky, Andrew R.
    Miller, David
    LaRose, Meredith, I
    Landsburg, Daniel J.
    Svoboda, Jakub
    Nasta, Sunita D.
    Gerson, James N.
    Barta, Stefan K.
    Chong, Elise A.
    Schuster, Stephen J.
    Paydar, Ima
    Maity, Amit
    Plastaras, John P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (01): : 178 - 188
  • [3] FEASIBILITY, SAFETY, AND EFFICACY OF RADIATION THERAPY AS A BRIDGING STRATEGY FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA
    Laprade, Selena
    Babadagli, Ege
    Islam, Nabil
    Samant, Rajiv
    Kennah, Michael
    Kekre, Natasha
    Maltez, Melissa
    Tan, Sherry
    Nair, Vimoj
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S48 - S48
  • [4] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
    Hamilton, Mark P.
    Miklos, David B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
  • [5] Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
    Manzar, Gohar S.
    Pinnix, Chelsea C.
    Dudzinski, Stephanie O.
    Marqueen, Kathryn E.
    Cha, Elaine E.
    Nasr, Lewis F.
    Yoder, Alison K.
    Rooney, Michael K.
    Strati, Paolo
    Ahmed, Sairah
    Nze, Chijioke
    Nair, Ranjit
    Fayad, Luis E.
    Wang, Michael
    Nastoupil, Loretta J.
    Westin, Jason R.
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Gunther, Jillian R.
    Dabaja, Bouthaina S.
    Wu, Susan Y.
    Fang, Penny Q.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [6] Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
    Hu, Bei
    Korsos, Victoria
    Palomba, M. Lia
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
    Zhou, Wenyujing
    Chen, Weihong
    Wan, Xiaochun
    Luo, Changru
    Du, Xin
    Li, Xiaoqing
    Chen, Qian
    Gao, Ruiwen
    Zhang, Xiaohan
    Xie, Mei
    Wang, Mingjun
    FRONTIERS IN GENETICS, 2022, 12
  • [8] Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma
    Steiner, Raphael E.
    Banchs, Jose
    Koutroumpakis, Efstratios
    Becnel, Melody
    Gutierrez, Cristina
    Strati, Paolo
    Pinnix, Chelsea C.
    Feng, Lei
    Rondon, Gabriela
    Claussen, Catherine
    Palaskas, Nicolas
    Karimzad, Kaveh
    Ahmed, Sairah
    Neelapu, Sattva S.
    Shpall, Elizabeth
    Wang, Michael
    Vega, Francisco
    Westin, Jason
    Nastoupil, Loretta J.
    Deswal, Anita
    HAEMATOLOGICA, 2022, 107 (07) : 1555 - 1566
  • [9] The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma
    Lutfi, Forat
    Holtzman, Noa G.
    Kansagra, Ankit J.
    Ali, Moaath Mustafa
    Bukhari, Ali
    Yan, Jingsheng
    Samanta, Santanu
    Gottlieb, David
    Kim, Dong W.
    Matsumoto, Lisa R.
    Gahres, Natalie
    Ruehle, Kathleen
    Lee, Seung T.
    Kocoglu, Mehmet H.
    Atanackovic, Djordje
    Yared, Jean A.
    Hardy, Nancy M.
    Molitoris, Jason
    Mohindra, Pranshu
    Rapoport, Aaron P.
    Dahiya, Saurabh
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 405 - 412
  • [10] Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic Leukemia
    Ladbury, Colton
    Salhotra, Amandeep
    Dandapani, Savita
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
12345